BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30786815)

  • 1. Activation of CD3
    Xue LJ; Mao XB; Liu XB; Gao H; Chen YN; Dai TT; Shao SW; Chen HM; Chu XY
    Cancer Biol Ther; 2019; 20(6):866-876. PubMed ID: 30786815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with
    Afkhamipour M; Kaviani F; Dalali S; Piri-Gharaghie T; Doosti A
    Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 38346161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
    Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
    J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Protection Against
    Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
    Front Immunol; 2019; 10():1185. PubMed ID: 31191547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
    Chehelgerdi M; Doosti A
    J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
    Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced gastric CD4
    Xu N; Ruan G; Liu W; Hu C; Huang A; Zeng Z; Luo S; Zhang Z; Fan M; Ye F; Xi T; Xing Y
    Helicobacter; 2019 Oct; 24(5):e12652. PubMed ID: 31414552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex-PCR-Based Screening and Computational Modeling of Virulence Factors and T-Cell Mediated Immunity in Helicobacter pylori Infections for Accurate Clinical Diagnosis.
    Oktem-Okullu S; Tiftikci A; Saruc M; Cicek B; Vardareli E; Tozun N; Kocagoz T; Sezerman U; Yavuz AS; Sayi-Yazgan A
    PLoS One; 2015; 10(8):e0136212. PubMed ID: 26287606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
    Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune responses induced by Helicobacter pylori improve the prognosis of gastric carcinoma.
    Xue LJ; Su QS; Yang JH; Lin Y
    Med Hypotheses; 2008; 70(2):273-6. PubMed ID: 17681432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori vaccine strategies--triggering a gut reaction.
    Hatzifoti C; Wren BW; Morrow WJ
    Immunol Today; 2000 Dec; 21(12):615-9. PubMed ID: 11114421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
    Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
    Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
    Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-related factors predicting prognosis of gastric cancer.
    Chang WJ; Du Y; Zhao X; Ma LY; Cao GW
    World J Gastroenterol; 2014 Apr; 20(16):4586-96. PubMed ID: 24782611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice.
    Todoroki I; Joh T; Watanabe K; Miyashita M; Seno K; Nomura T; Ohara H; Yokoyama Y; Tochikubo K; Itoh M
    Biochem Biophys Res Commun; 2000 Oct; 277(1):159-63. PubMed ID: 11027657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric Subserous Vaccination With
    Liu W; Zeng Z; Luo S; Hu C; Xu N; Huang A; Zheng L; Sundberg EJ; Xi T; Xing Y
    Front Immunol; 2019; 10():1115. PubMed ID: 31156652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?
    van den Engel NK; Winter H; Rüttinger D; Shau I; Schiller M; Mayer B; Moudgil T; Meimarakis G; Stolte M; Jauch KW; Fox BA; Hatz RA
    Clin Immunol; 2006 Sep; 120(3):285-96. PubMed ID: 16765089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.